Literature DB >> 18657097

FDAMA 1997 Section 114: another look.

Joseph Jackson.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18657097     DOI： 10.1111/j.1524-4733.2008.00432.x

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

1.  Should off-label drugs be included as comparators in pharmacoeconomic studies?

Authors:  Surrey M Walton; Glen T Schumock
Journal:  Pharmacoeconomics       Date:  2014-11       Impact factor: 4.981

2.  An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claims.

Authors:  Satabdi Chatterjee; Harshali K Patel; Sujit S Sansgiry
Journal:  Pharm Pract (Granada)       Date:  2012-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.